Sublocade Solution
Product Images NDC 12496-0100

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Sublocade (NDC 12496-0100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indivior Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sub0a 0038 01

FDA Label Image

Sub0a 0038 02

FDA Label Image

Sub0a 0038 03

FDA Label Image

Sub0a 0038 04

FDA Label Image

Sub0a 0038 05

FDA Label Image

Sub0a 0038 06

FDA Label Image

Sub0a 0038 07

FDA Label Image

Sub0a 0038 08

FDA Label Image

Sub0a 0038 09

FDA Label Image

Sub0a 0038 10

FDA Label Image

Sub0a 0038 11

FDA Label Image

Sub0a 0038 12

FDA Label Image

Sub0a 0038 13

FDA Label Image

Sub0a 0038 14

The text describes a chart showing the percentage of subjects at different levels (100%, 80%, 60%, 40%, 20% and 0%) in a clinical trial for a medication called SUBLOCADE, in two different doses and with an IDC component. The first dose is 300mg/300mg, the second is 300mg/100mg, and the control is a placebo with IDC. The chart seems to be measuring something related to the number of opioid-free weeks.*

FDA Label Image

Sub0a 0038 15

This is a prescription for Sublocade, a subcutaneous injection used for abdominal pain. The users are warned to read all the instructions carefully before the usage of the injection. The needle should be attached during administration, and the needle provided with the injection should only be used. The injection must be kept out of reach of children and should be stored at a temperature between 29-8°C (35.6°-46.4°F). The users must remove the Sublocade from the refrigerator 15 minutes before administering it. There is a warning that serious harm or death can occur if it is injected intravenously. It is also mentioned that after 7 days, the injection should be discarded if kept outside the refrigerator. For more information, SUBLOCADE com can be visited.*

FDA Label Image

Sub0a 0038 16

Sublocade' @ is a single dose injection used for abdominal subcutaneous injection only. It contains 100mg/0.5mL of Buprenorphine in the ATRIGEL Delivery System and an oxygen absorber. It is manufactured by Indivior Inc. and distributed by AMRI, Burlington. The product needs to be stored at 2°-8°C and discarded if left at room temperature for more than 7 days. The needle should be attached at the time of administration, and only the provided needle should be used. The expiry date for LOTX00 is 12/.*

FDA Label Image

Sub0a 0038 17

Sublocade is a sterile single-dose injection used for subcutaneous use. It contains buprenorphine extended-release and is only available with a prescription. The product has a barcode and a manufacturing location in Massachusetts. The lot number and expiration date are also provided, but there is no available information regarding the dosage or quantity as they are not mentioned in the provided text.*

FDA Label Image

Sub0a 0038 18

Sublocade is a medication that comes in injection form and is used only for abdominal subcutaneous injection. It should be kept out of reach of children. The accompanying full prescribing information needs to be read prior to use. Serious harm or death could result if injected intravenously. The product needs to be removed from the fridge at least 15 minutes before administration and must reach room temperature to be used. The needle provided should be attached at the time of administration and stored between 35.6°F and 46.4°F. If left at room temperature for over 7 days, it should be discarded.*

FDA Label Image

Sub0a 0038 19

Sublocade @ is a sterile single-dose injection used for abdominal or subcutaneous administration with 300 mg/1.5 mL of buprenorphine in the ATRIGEL® delivery system per prefilled syringe. The product should be stored between 2°-8°C (35.6°-46.4°F), but may be kept at room temperature for up to 7 days prior to administration. After this time, the product should be discarded. The needle provided should be used for administration after the product has been removed from the refrigerator and allowed to warm to room temperature for at least 15 minutes. This extended-release medication is to be used only as prescribed and kept away from children.*

FDA Label Image

Sub0a 0038 20

This is a description of a prescription medication with the NDC code 12496-0300-5 called Sublocade, which is a buprenorphine extended-release injection for subcutaneous use. The medication is for subcutaneous injection only and is designed for single dose use. There is a lot number (XXXXXXXX) and an expiration date (1272017) provided. The manufacturer is listed as AMRI with an address in Burlington, MA. A linear barcode is present as well as an unvarnished area for wrap.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.